Ингамист 100 мг/мл 3 мл раствор для инъекций

Land: Kirgisistan

Tungumál: rússneska

Heimild: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Virkt innihaldsefni:

Ацетилцистеин

Fáanlegur frá:

ООО "Юрия-Фарм" (ООО "Юрия-Фарм")

ATC númer:

R05CB01

INN (Alþjóðlegt nafn):

Acetylcysteine

Skammtar:

100 мг/мл 3 мл

Lyfjaform:

раствор для инъекций

Einingar í pakka:

№10

Gerð lyfseðils:

по рецепту

Framleitt af:

ООО "Юрия-Фарм" (Украина)

Vörulýsing:

ПЖВЛС: нет

Leyfisdagur:

2017-10-27

Vara einkenni

,aHCTPy-KItI,Ifl
IIo
MEAIIIIIIHCKOMy
IIP}IMEHEHIIIO
IIPETIAPATA
o6ecneqeulrq
tl
yTBEPx(flAlo
3aprecrureJlb
ArrPeICToPa
L-qrnctezua,
vr3
IIHIAMI,ICT
(INGAMIST)
I'opronoe
tla3,Ballulre
Hnrantucr
Ilrleiru)'map
oAltroo
HerIareHToBaHHoe
HaHMeHoBaH[e
,/\uetu;upcrellu;
Cocran
,tl
e
u
c:
tn
tymt
u4u
et
B
c,
ul
e c
m
6
o
:
ar\ervlnqu
crel'IH
1
0
0
u
r/ul
;
lllcnoivutaanrctil)Hbte
6et4ecmsa:
[u:frarpvflsAerar,
HuLpufl,rI'IApOKC[IA,
BOAa
ALs
IEnlexuuft'
")Ienapc'rneHlla,il
r[oPua
llac'rnop
rJs
un:sexqufi
.
lDnucasue
]lpo:pa.rnrag
6ecueetHarl
xI'IAKocTb
co
cla6uM
3a[axoM
cepbl'
Jlogle
Bct(pblltl,rll
aM[yJIbI
[pI{
AII{TeILHOM
KOHTaKTe
c
Bo3AyxOM
MoXeT
IIOflBJLTICfl'
Cilaiuir
pos
onr
o-
t[
aoretosblfi
orreHoK.
,Oa
pnrarcotlepaIIeBTr{rIecrafl
rpy[na
,lJ.rxap
ruana.rcxql4te
llpeilapaTbl.
Myronuturu.
AqeTUJIIIIICTeI'IH.
Kol,t\TX
110i;CB01
(Dapua
nruroruqecxrle
csofi
crna
Qa,pmaxttituuatwuxa
Aq,era1qu,lreuH
pa3xr.rxaer
MoKpory.
.{axe
B
crpyxType
aIIerI4JIIIucreI{Ha
cyJIb(brI{ApIaJIbHbIe
rpynrrbr
()noccr6crByror
pa3pbrBy
Ar,rcyJrbibI,IAHbIx
cssgefi
KI'IcJILrx
MyKoTIoJII'IcaxapI{AoB
MOI(poTbr,
rrTo
Ipr.rBoAr,rT
K
AerroJrflpr,r3aul{I,I
MyKOIIpOTeLIAOB
I,I
yl[eHbIIIeHI'I]O
BS3KOCTI',I
CJII{3}I.
flp
enaparr
coxpianfl
eT
aKTI,IBHocTb
npIn
HaJII{q}Iu
rsOfi
uOfi
MOKpOTbI.
Auelunlucreuu
oKa3brBaer
aHTr.roKclrAaHTHoe
Aeficts[e,
o6ycnoueuuoe
HarI{qHeM
uyxteor$u:.uruojl
ruolosofi
SH-rpyrrrrbr,
JrerKo
orAaer
BoAopoA,
uefirpalusy,
oKHcnI'ITeJIbHbIe
parllrKa[b].
3aUlirr-qr1li
MexaHr.r3M
arlerr{nqucrer,rHa
ocHoBaH
Ha
cnoco6uocru
ero
peaKTI{BHbrx
cyrrrlpr.r,I,rlpl,IJlblIbD(
rpyrrl
cBfl3blBaTb
CnO6oAHrte
paAI'IKaJIbI.
AqeUarrUUCT€rI,IH
JIerKo
IIpOHI{KaeT
BHyrpb
KJIeTKI'I,
AeaqeT}IJI[IpyeTcf
AO
Koropo
ro cl{Ilre3llpyercfl
BHyrplIKJIeroqHbIfi
rmotaruou.
Irtorar:uog
BbrcoKopeartunurrfi
Tpr.rnerITlIA,
uorqurrft
aHTlloKcI'IAaHT,
III'ITonporeKTop,
3&)iB&TrJr)ilorg{fi
gHAoreHHrre
u
3K3oreHHbIe
cBo6oAHbIe
paII'IKaJIbI
Ll
roKc}IHbI.
,forrrrurrr.r,
rpeAorBptuqaer
llcroule*lle
u
cnoco6ctnyet
IIoBbrIIreHI'Irc
cl4Hre3a
,lr*rroraroqlloro
rJrlorar[IoHa,
yqacrBy